X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf
https://health.economictimes.indiatimes.com/news/pharma/alembic-pharma-subsidiary-aleor-dermaceuticals-gets-usfda-nod-for-acne-gel/93423857
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214185
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209641
https://www.expresspharma.in/zydus-lifesciences-receives-final-approval-from-us-fda-for-adapalene-and-benzoyl-peroxide-topical-gel/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214553
https://www.fiercepharma.com/pharma/sol-gel-gets-fda-approval-encapsulated-skin-disease-drug#:~:text=Sol%2DGel%20Technologies'%20work%20to,based%20on%20its%20microencapsulation%20technology.
https://www.globenewswire.com/news-release/2022/04/25/2427977/0/en/Sol-Gel-Technologies-and-Galderma-Announce-FDA-Approval-of-EPSOLAY.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-22-2021-1640158210.pdf
https://www.globenewswire.com/news-release/2021/12/21/2355957/0/en/Sol-Gel-Technologies-Announces-Positive-Update-Related-to-FDA-Review-Status-of-EPSOLAY.html
https://www.business-standard.com/article/companies/zydus-cadila-gets-tentative-nod-from-usfda-to-market-generic-acne-drug-121100800461_1.html
https://www.prnewswire.com/news-releases/larissa-manoela-e-dermotivin-r-benzac-dao-dicas-de-skincare-para-peles-oleosas-e-acneicas-809647007.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208108
https://www.business-standard.com/article/news-cm/glenmark-pharma-rises-after-usfda-nod-for-generic-acne-treatment-gel-119111100800_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209610
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205397
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207194
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206575
https://www.fiercepharma.com/manufacturing/tergus-pharma-to-become-full-fledged-cdmo-new-manufacturing-facility
https://www.biospectrumasia.com/news/25/13036/glenmark-receives-anda-approval-for-clindamycin-and-benzoyl-peroxide-gel-15.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210794
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209148
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207194
https://www.pharmacompass.com/pdf/news/List-of-New-Paragraph-IV-Certifications-as-of-Aug-21-2018-1534919998.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208757
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208776
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206164
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-23-2018-1527054176.pdf
https://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-the-generic-version-of-onexton-gel-300588900.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205033
http://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-the-generic-version-of-acanya-gel-300521093.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204087
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206959
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-26-2017-1493180509.pdf
http://raps.org/Regulatory-Focus/News/2017/04/04/27265/Asia-Regulatory-Roundup-Australia-Considers-Some-DTC-Drug-Ads-4-April-2017/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
http://www.fiercepharma.com/manufacturing/perrigo-recalling-162-000-tubes-acne-gel
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208683
http://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-generic-version-of-epiduo-gel-300321435.html
http://www.prnewswire.com/news-releases/perrigo-announces-fda-approval-and-launch-of-the-generic-version-of-benzaclin-pump-topical-gel-300260734.html
http://www.prnewswire.com/news-releases/valeant-announces-new-us-fulfillment-agreements-with-walgreens-plans-to-further-extend-distribution-to-independent-pharmacies-300192840.html
https://www.pharmacompass.com/pdf/news/actavis-generic-adapalene-and-benzoyl-peroxide-approved-in-us-for-acne-1443791385.pdf
https://www.pharmacompass.com/pdf/news/lynes-generic-erythromycin-and-benzoyl-peroxide-approved-in-us-for-acne-1443179864.pdf
http://www.prnewswire.com/news-releases/perrigo-announces-fda-approval-and-launch-of-the-ab-rated-generic-version-of-benzaclin-topical-gel-300146992.html
Market Place
Share 
